###begin article-title 0
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration
###end article-title 0
###begin p 1
J. Duyster and J. Schwaller contributed equally to this paper.
###end p 1
###begin p 2
###xml 1180 1188 <span type="species:ncbi:9606">patients</span>
FLT3-ITD-mediated leukemogenesis is associated with increased expression of oncogenic PIM serine/threonine kinases. To dissect their role in FLT3-ITD-mediated transformation, we performed bone marrow reconstitution assays. Unexpectedly, FLT3-ITD cells deficient for PIM1 failed to reconstitute lethally irradiated recipients, whereas lack of PIM2 induction did not interfere with FLT3-ITD-induced disease. PIM1-deficient bone marrow showed defects in homing and migration and displayed decreased surface CXCR4 expression and impaired CXCL12-CXCR4 signaling. Through small interfering RNA-mediated knockdown, chemical inhibition, expression of a dominant-negative mutant, and/or reexpression in knockout cells, we found PIM1 activity to be essential for proper CXCR4 surface expression and migration of cells toward a CXCL12 gradient. Purified PIM1 led to the phosphorylation of serine 339 in the CXCR4 intracellular domain in vitro, a site known to be essential for normal receptor recycling. In primary leukemic blasts, high levels of surface CXCR4 were associated with increased PIM1 expression, and this could be significantly reduced by a small molecule PIM inhibitor in some patients. Our data suggest that PIM1 activity is important for homing and migration of hematopoietic cells through modification of CXCR4. Because CXCR4 also regulates homing and maintenance of cancer stem cells, PIM1 inhibitors may exert their antitumor effects in part by interfering with interactions with the microenvironment.
###end p 2
###begin p 3
###xml 351 380 351 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Chalandon and Schwaller, 2005</xref>
###xml 573 591 573 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Giles et al., 2005</xref>
###xml 772 796 772 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">von Bubnoff et al., 2003</xref>
###xml 1246 1275 1242 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Chalandon and Schwaller, 2005</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 742 750 <span type="species:ncbi:9606">patients</span>
Genetic alterations that lead to uncontrolled protein tyrosine kinase (PTK) activity are a hallmark of human malignant myeloproliferative disorders. Fusion genes involving ABL or PDGFR are the molecular correlate of chronic myeloproliferative disorders, whereas activating mutations of FLT3 are recurrently found in human acute myeloid leukemia (AML; Chalandon and Schwaller, 2005). The success of small molecules that block oncogenic tyrosine kinase activity, such as imatinib-mesylate (Gleevec; Novartis), provided a proof of principle for targeted antileukemic therapy (Giles et al., 2005). However, the successful clinical use of such compounds has been challenged by the development of drug resistance and a limited clinical efficacy in patients with acute leukemia (von Bubnoff et al., 2003). To overcome these limitations, identification of critical signaling mediators downstream of an oncogenic tyrosine kinase is essential to identify new targets that would allow the development of an efficient combined therapeutic approach. There is strong evidence that most oncogenic tyrosine kinases mediate malignant transformation through parallel activation of several signaling pathways such as JAK-STAT, PI3K-AKT, RAS-RAF-MAPK, or NF-kappaB (Chalandon and Schwaller, 2005).
###end p 3
###begin p 4
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 189 209 189 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Mikkers et al., 2002</xref>
###xml 553 573 553 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Mikkers et al., 2004</xref>
###xml 647 663 647 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mui et al., 1996</xref>
###xml 910 932 910 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Schwaller et al., 2000</xref>
###xml 1056 1074 1056 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Amson et al., 1989</xref>
###xml 1076 1095 1076 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Mizuki et al., 2003</xref>
###xml 1097 1119 1097 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Hammerman et al., 2005</xref>
###xml 1580 1596 1568 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kim et al., 2005</xref>
###xml 1598 1615 1586 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adam et al., 2006</xref>
###xml 1617 1636 1605 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Agrawal et al. 2008</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 1563 1568 <span type="species:ncbi:9606">human</span>
Retroviral gene tagging in c-myc-induced lymphomas in mice has led to the identification of the PIM family of serine/threonine kinases that encompasses three members: PIM1, PIM2, and PIM3 (Mikkers et al., 2002). Transgenic mouse models have demonstrated that PIM kinases exert their oncogenic potential mainly in cooperation with various oncogenes. Targeted inactivation of one, two, or all three PIM genes resulted in mice with some growth retardation and mild defects in steady-state hematopoiesis, but these mice were fertile with a normal lifespan (Mikkers et al., 2004). PIM1 has been characterized as one of the first target genes of STAT5 (Mui et al., 1996). In vitro and in vivo experimental work has demonstrated that constitutive STAT5 activation is a hallmark of a wide spectrum of hematological malignancies and that STAT5 is an essential mediator for transformation by oncogenic tyrosine kinases (Schwaller et al., 2000). Interestingly, both PIM1 and PIM2 are frequently overexpressed in leukemia and lymphoma as well as in some solid tumors (Amson et al., 1989; Mizuki et al., 2003; Hammerman et al., 2005). As PIM kinases are constitutively active and their expression is regulated predominantly by transcription and/or proteasomal degradation, this suggests that PIM kinases play an important role in hematological malignancies. Further in vitro functional studies have provided evidence that activation of PIM1 and/or PIM2 is important for malignant transformation by oncogenic tyrosine kinases such as FLT3-ITD, expressed in approximately25% of human AML cases (Kim et al., 2005; Adam et al., 2006; Agrawal et al. 2008). These studies indicated that small molecules inhibiting PIM kinases could provide a promising therapeutic avenue for hematological malignancies. However, it remains unclear whether one or both of the hematopoietically expressed PIMs (PIM1 and PIM2) are essential for mediating disease manifestations induced by oncogenic PTKs.
###end p 4
###begin p 5
###xml 234 254 234 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lapidot et al., 2005</xref>
###xml 256 278 256 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ratajczak et al., 2006</xref>
###xml 526 550 526 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Juarez and Bendall, 2004</xref>
###xml 552 574 552 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Burger and Kipps, 2006</xref>
###xml 694 715 694 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Rombouts et al., 2004</xref>
###xml 717 734 717 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Spoo et al., 2007</xref>
###xml 907 924 907 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Zeng et al., 2006</xref>
###xml 926 945 926 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Juarez et al., 2007</xref>
###xml 1150 1172 1150 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Croker and Allan, 2008</xref>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
CXCL12, which is also known as SDF1 (stromal cell-derived factor 1), mediates signals through the chemokine receptor 4 (CXCR4) that are essential for homing and maintenance of hematopoietic stem cells (HSCs) in the bone marrow niche (Lapidot et al., 2005; Ratajczak et al., 2006). There is increasing evidence that CXCR4 is a key regulator of homing and retention of leukemic stem cells within the marrow niche that allows these cells to escape spontaneous and chemotherapy-induced cell death as well as promoting metastasis (Juarez and Bendall, 2004; Burger and Kipps, 2006). These findings are supported by the negative prognostic impact of high CXCR4 expression levels in patients with AML (Rombouts et al., 2004; Spoo et al., 2007). Consequently, targeting leukemic stem cells within the bone marrow by disruption of the CXCL12-CXCR4 interaction by small molecule inhibitors has been recently proposed (Zeng et al., 2006; Juarez et al., 2007). There is strong evidence that the CXCL12-CXCR4-mediated growth promotion and migration is not limited to leukemia but is also essential for the spreading of tumor-initiating cells of many solid tumors (Croker and Allan, 2008).
###end p 5
###begin p 6
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Using bone marrow cells from PIM knockout mice, we show that in vivo malignant transformation by the FLT3-ITD mutant is independent of PIM2. However, our experiments unexpectedly unravel that PIM1 is important for bone marrow reconstitution in lethally irradiated hosts. Further functional analysis suggests that PIM1 regulates surface CXCR4 expression in hematopoietic cells lines and in AML blasts. Collectively, our work reveals a previously unknown function of the oncogenic PIM1 serine/threonine kinase as regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin p 8
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 461 469 461 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 628 631 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 709 701 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 891 894 891 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1228 1231 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1239 1242 1239 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1380 1388 1380 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1488 1491 1488 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1707 1710 1707 1710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1824 1825 1824 1825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1912 1920 1912 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 2007 2010 2007 2010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2163 2171 2163 2171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 2368 2371 2368 2371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2622 2623 2622 2623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2708 2711 2708 2711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2836 2839 2836 2839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2876 2884 2876 2884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1255 1259 <span type="species:ncbi:10090">Mice</span>
###xml 1711 1715 <span type="species:ncbi:10090">mice</span>
###xml 2059 2063 <span type="species:ncbi:10090">mice</span>
###xml 2227 2231 <span type="species:ncbi:10090">mice</span>
###xml 2297 2301 <span type="species:ncbi:10090">mice</span>
###xml 2398 2402 <span type="species:ncbi:10090">mice</span>
To investigate the role of PIM kinases in hematological diseases induced by oncogenic PTKs, we expressed the constitutively active FLT3-ITD mutant in primary mouse bone marrow cells. Expression of FLT3-ITD in WT cell induced growth factor-independent growth in liquid culture as well as in methylcellulose. Compared with WT bone marrow, expression of FLT3-ITD in PIM1-/- cells resulted in a significantly lower number of colonies growing with and without IL-3 (Fig. 1 A). No differences in colony formation or growth properties were observed when FLT3-ITD was expressed in bone marrow cells from mice lacking the PIM2 gene (PIM2-/-) compared with WT mice when grown in presence or in absence of IL-3 (Fig. 1 A). Liquid culture of the cells over 5 d revealed no difference in viability but a general reduced growth rate of bone marrow cells originating from PIM1-/- animals compared with PIM2-/- or WT mice (). These in vitro results suggest that PIM1, and not PIM2, is involved in signaling events that are essential for IL-3 and/or FLT3-ITD-regulated proliferation. To further study the role of PIMs in FLT3-ITD-mediated leukemogenesis in vivo, we performed bone marrow transduction/transplantation experiments using WT or PIM1-/- or PIM2-/- donor mice. Mice that were transplanted with cells lacking PIM1 showed no hematological disorder during 1-yr posttransplant observation (Fig. 1 B). Histological analysis of the normal sized spleens of animals that had been transplanted with PIM1-/- FLT3-ITD-expressing cells did not show any significant pathological changes 6 mo after transplant (, top). In contrast, all animals that received a transplant of FLT3-ITD-transduced bone marrow cells from WT or PIM2-/- mice developed a myeloproliferative disorder characterized by a massive expansion of EGFP-positive myeloid (CD11b+) cells in the peripheral blood assessed by flow cytometry 26 d after transplantation (Fig. 1 C). There was no significant difference in survival between recipients of WT versus PIM2-/- bone marrow transduced with FLT3-ITD, with both mice groups succumbing to a fatal disease within a median survival time of 108 and 138 d, respectively (Fig. 1 B). Histopathological examination of the spleens of sick mice revealed extensive infiltration with neoplastic myeloid cells in mice that received a transplant of FLT3-ITD-infected WT as well as PIM2-/- bone marrow cells (). All mice receiving a transplant of FLT3-ITD-transduced bone marrow developed exactly the same mixed myeloid/T lymphoid phenotype, irrespective of the genetic background of the transplanted bone marrow (). Observation of the EGFP+ reconstituted cells revealed significant expansion of FLT3-ITD-expressing WT or PIM2-/- cells within the first month after transplant. In contrast, although detectable over several weeks, FLT3-ITD-expressing PIM1-/- underwent no significant expansion (Fig. 1 D).
###end p 8
###begin p 9
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro and in vivo FLT3-ITD&#8211;mediated transformation in the presence and absence of PIM serine/threonine kinases.</bold>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 489 492 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MigRI</italic>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1309 1312 1309 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 804 809 <span type="species:ncbi:10090">mouse</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
In vitro and in vivo FLT3-ITD-mediated transformation in the presence and absence of PIM serine/threonine kinases. (A) Comparative analysis of clonogenic growth of FLT3-ITD-expressing bone marrow cells from FVB/N (WT) and PIM1-/- or PIM2-/- mice. 104 cells were sorted (EGFP+) 48 h after infection and plated in methylcellulose in presence or absence of IL-3. The figure represents one out of three independent experiments performed in triplicates. (B) Kaplan Meier survival plot. WT, PIM1-/-, or PIM2-/- bone marrow was transduced with FLT3-ITD or empty vector (MigRI) as indicated and transplanted into sublethally irradiated (750 rad) recipient mice. All mice that underwent transplantation with FLT3-ITD-transduced WT or PIM2-/- bone marrow died or were sacrificed because of disease conditions. One mouse transplanted with FLT3-ITD-transduced WT bone marrow showed extended survival and no signs of disease. n, number of mice transplanted and analyzed. Three independent transplantations were performed (see  for details). (C) Flow cytometric analysis of peripheral blood samples in the course of the disease (26, 52, and 90 d after transplantation). Two-parameter dot plots show expression of myeloid lineage-specific antigen CD11b versus EGFP. The figure represents one out of three (WT) and four (PIM2-/-) analyzed mice, respectively. (D) Percentage of EGFP-positive leukocytes in the peripheral blood of transplanted mice determined at the indicated time points. Data represents the mean +/- SD of three to four analyzed animals as indicated.
###end p 9
###begin p 10
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 834 847 834 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mig-IRES-EGFP</italic>
###xml 945 953 945 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1063 1066 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1109 1112 1109 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1381 1384 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1429 1447 1429 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Domen et al., 1993</xref>
###xml 1485 1493 1485 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1587 1588 1587 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1593 1594 1593 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1598 1599 1598 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1631 1634 1631 1634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
As bone marrow harvest, as well as the retroviral infection rate of WT, PIM1-/-, or PIM2-/- bone marrow cells, did not differ (unpublished data), the absence of any FLT3-ITD-mediated disease might be explained by the inability of PIM1-/- to reconstitute irradiated animals. During the first series of experiments, we applied a nonmyeloablative irradiation dose to FVB/N mice (750 rad). To further exclude the possibility of a homing failure in PIM1-/- cells, we increased the irradiation to a lethal dose of 900 rad and repeated the experiments. Again, animals receiving FLT3-ITD-expressing cells from WT and PIM2-/- donors developed an identical myelolymphoproliferative disorder to that described in the previous paragraph (unpublished data). In contrast, all recipients receiving PIM1-/- bone marrow expressing the control vector (Mig-IRES-EGFP) alone or FLT3-ITD died rapidly (within 22 d) because of the lack of bone marrow reconstitution (Fig. 2 A). Careful examination of the hematologic parameters showed that in contrast to animals transplanted with PIM2-/- and WT cells, in recipients receiving PIM1-/- cells the white cell, red cell, and platelet counts declined rapidly in the first 2 wk after transfer (). This unexpected observation suggests that PIM1 might play an essential role in early bone marrow reconstitution. Although previous work has demonstrated that PIM1-/- bone marrow cells show some growth defects (Domen et al., 1993), as shown in colony-forming assays (Fig. 1 A), the number of HSCs, as assessed by the determination of the number of lineage-negative (Lin- Sca1+ Kit+) cells, was not reduced in PIM1-/- when compared with WT animals (FVB/N; not depicted).
###end p 10
###begin p 11
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 384 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 620 628 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 758 761 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 908 916 908 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 950 953 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
The rapid declines in hematopoietic cells of all lineages, leading to death of animals within the first month after transplant, suggest that PIM1-/- HSCs have not only a proliferation defect but also impaired migration and/or homing capacities. To understand the role of PIM1 in HSC homing, we performed a series of experiments in which we labeled bone marrow cells from WT or PIM1-/- mice with a vital dye (CFSE), transplanted equal numbers of positively labeled and viable cells into lethally irradiated recipients, and determined the amount of cells in spleen and bone marrow 4 and 20 h after transplant. As shown in Fig. 2 B, a significant time-independent decrease in CSFE-labeled cells was observed in the bone marrow and spleen after transferring PIM1-/- cells compared with cells from WT donor animals. No significant difference in viability of CFSE-labeled cells was observed between the genotypes (Fig. 2 C). This finding suggests that PIM1-/- bone marrow cells are impaired in their capacity to home to hematopoietic organs.
###end p 11
###begin p 12
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIM1<sup>&#8722;/&#8722;</sup> bone marrow cells do not reconstitute lethally irradiated recipient animals and have an impaired homing capacity.</bold>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 630 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
PIM1-/- bone marrow cells do not reconstitute lethally irradiated recipient animals and have an impaired homing capacity. (A) Overall survival (Kaplan-Meier plot) of lethally irradiated (900 rad) recipients receiving WT, PIM1-/-, or PIM2-/- bone marrow cells. n, number of mice transplanted and analyzed. Two sets of independent transplantations were performed. (B) Homing of CFSE-labeled bone marrow cells from PIM1-/- and WT FVB/N mice to the bone marrow (top) and the spleen (bottom) of WT recipients. Data represent the mean +/- SD of three experiments performed in triplicates. (C) Viability of bone marrow cells from PIM1-/- and WT FVB/N mice 4 and 20 h after CFSE stain. Data represent the mean +/- SD of three experiments performed in duplicates.
###end p 12
###begin p 13
###xml 115 139 115 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Juarez and Bendall, 2004</xref>
###xml 141 161 141 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lapidot et al., 2005</xref>
###xml 163 185 163 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Burger and Kipps, 2006</xref>
###xml 187 209 187 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ratajczak et al., 2006</xref>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 617 620 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 700 708 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 881 883 873 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 978 986 970 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 1137 1140 1129 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
The CXCL12-CXCR4 signaling axis has been proposed to be essential for homing and migration of hematopoietic cells (Juarez and Bendall, 2004; Lapidot et al., 2005; Burger and Kipps, 2006; Ratajczak et al., 2006). To explore the role of these signaling mediators, we compared WT, PIM1-/-, and PIM2-/- cells for their capacity to migrate over a CXCL12 gradient. As shown in Fig. 3 A, bone marrow cells lacking PIM1 are significantly impaired in migration. In contrast, PIM2-/- bone marrow cells were not defective in migration toward CXCL12. Interestingly, we found that bone marrow cells from PIM1-/- mice, but not PIM2-/- mice, expressed lower levels of surface CXCR4 when analyzed by flow cytometry (Fig. 3 B) but did not show any differences in the expression of other surface molecules involved in homing such as the integrins alpha4 and alpha5 (). In addition, CXCL12-induced Ca2+ flux was significantly reduced in bone marrow cells lacking PIM1 when compared with WT cells (Fig. 3 C). Furthermore, we observed a modest but reproducible impairment of CXCL12-induced phosphorylation of ERK in the lineage-negative subpopulation of PIM1-/- bone marrow cells analyzed by flow cytometry and immunoblotting ( and not depicted). These observations suggested that the serine/threonine kinase PIM1 could functionally regulate CXCR4.
###end p 13
###begin p 14
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 144 0 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decreased steady-state CXCR4 surface expression of PIM1<sup>&#8722;/&#8722;</sup> bone marrow cells is associated with impaired migration and CXCL12-induced signaling.</bold>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 525 528 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 534 537 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 860 863 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
###xml 707 710 <span type="species:ncbi:10116">rat</span>
Decreased steady-state CXCR4 surface expression of PIM1-/- bone marrow cells is associated with impaired migration and CXCL12-induced signaling. (A) Bone marrow cells from PIM1-/-, PIM2-/-, and WT FVB/N mice were allowed to migrate toward a 300-ng/ml CXCL12 gradient along with background migration as indicated. The migration index was calculated as a percentage of input cells. Data represent the mean +/- SD of three experiments performed in triplicates. (B) Cell surface expression of CXCR4 of bone marrow cells from PIM1-/-, PIM2-/-, and WT mice was analyzed by staining with PE-conjugated anti-mouse CD184 antibody (open histogram). The level of nonspecific binding was assessed using a PE-conjugated rat IgG2b as isotype control (gray histogram). Data represent one out of three experiments. (C) Calcium flux was monitored in freshly isolated WT and PIM-/- bone marrow cells after stimulation with 300 ng/ml CXCL12. Data represent one out of three experiments.
###end p 14
###begin p 15
###xml 226 234 226 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 328 336 328 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 847 855 847 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 917 920 917 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1102 1110 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 1425 1445 1425 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pogacic et al., 2007</xref>
###xml 1604 1612 1604 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 1861 1869 1857 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 F</xref>
###xml 1405 1410 <span type="species:ncbi:9606">human</span>
###xml 1448 1453 <span type="species:ncbi:9606">Human</span>
To further experimentally address this possibility, PIM1 expression was knocked down by retrovirally expressed small interfering RNAs (siRNAs) in Ba/F3 cells and resulted in a significant decrease of CXCR4 surface expression (Fig. 4 A). Interestingly, Western blot analysis revealed no change in total CXCR4 protein expression (Fig. 4 B). Furthermore, expression of a dominant-negative PIM1-KD mutant also down-regulated cell surface CXCR4 expression, suggesting that PIM1 kinase activity is necessary (). These data suggested that PIM1 does not influence the total protein level of CXCR4, but may control the surface presentation, and that PIM1 activity might be necessary. We therefore tested whether the reexpression of PIM1 in PIM1-/- bone marrow cells could rescue surface CXCR4 expression and migration toward a CXCL12 gradient. As shown in Fig. 4 C, retroviral expression of PIM1 in bone marrow cells from PIM1-/- background increased surface CXCR4 expression to the level of WT littermates. In addition, expression of PIM1 restored the capability of cells to efficiently migrate toward CXCL12 (Fig. 4 D). These results strongly suggested that PIM1 regulates CXCR4 surface expression and function in hematopoietic cells. To further test the hypothesis that PIM1 kinase activity is involved in regulation of CXCR4 surface expression, we used a recently identified potent small molecule inhibitor of human PIM1 (K00486; Pogacic et al., 2007). Human JURKAT acute lymphoblastic leukemia cells that express high levels of PIM1 and surface CXCR4 were used in this experiment. Interestingly, as shown in Fig. 4 E, short-term nontoxic treatment (2 h, 10 microM) with the PIM inhibitor K00486 led to a transient but significant decrease of CXCR4 surface expression and reduced migration of the cells toward a CXCL12 gradient without affecting cellular viability (Fig. 4 F). Treatment of the cells with the PIM inhibitor also impaired CXCL12-induced, but not PMA-induced, ERK phosphorylation (Fig. S7 B). These results strongly suggested that PIM1 might act as functional regulator of the CXCL12-CXCR4 signaling axis.
###end p 15
###begin p 16
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIM1 activity regulates CXCR4 surface expression in hematopoietic cells.</bold>
###xml 754 757 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 790 805 790 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pMSCV mPIM1-YFP</italic>
###xml 1041 1044 1041 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1073 1088 1073 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pMSCV mPIM1-YFP</italic>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 925 930 <span type="species:ncbi:10090">mouse</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
PIM1 activity regulates CXCR4 surface expression in hematopoietic cells. (A) Down-regulation of PIM1, but not PIM2, resulted in reduced surface expression of CXCR4 in Ba/F3 cells. Ba/F3 cells were retrovirally transduced with pLMP (∅), pLMP-PIM1, or pLMP-PIM2 (expressing siRNA). Cell surface expression of CXCR4 was analyzed by staining with PE-conjugated anti-mouse CD184 antibody (open histogram). The level of nonspecific binding was assessed as described in 3B (gray histogram). Data represent one out of three experiments. (B) Down-regulation of PIM1 and PIM2 protein expression was confirmed by Western blot analysis. No change in total CXCR4 expression was observed. The figure represents one out of three independent experiments. (C) WT and PIM1-/- bone marrow was transduced with pMSCV mPIM1-YFP or empty vector (MYFP) as indicated. Cell surface expression of CXCR4 was analyzed by staining with PE-conjugated anti-mouse CD184 antibody. Data represent the mean of two independent experiments. (D) Bone marrow cells from WT and PIM1-/- FVB/N mice, transduced with pMSCV mPIM1-YFP or empty vector (MYFP) as indicated, were allowed to migrate toward a 300-ng/ml CXCL12 gradient along with background migration as indicated. The migration index was calculated as a percentage of input cells. Data represent the mean +/- SD of three independent experiments performed in triplicates (one-way ANOVA: *, P </= 0.05). (E) Treatment of human JURKAT leukemia cells with a small-molecule PIM1 inhibitor (K00486, 10 microM) leads to a transient but significant reduction of surface CXCR4 expression after 2 h (dotted line) and 24 h (gray line). Viability of the cells was not significantly changed within the time of the experiment determined by 7-AAD staining (not depicted). Data represent one of three experiments. (F) JURKAT cells were allowed to migrate toward a 100-ng/ml CXCL12 gradient with or without pretreatment with 10 microM of the K00486 PIM inhibitor for 2 h. Data represent the mean +/- SD of three experiments.
###end p 16
###begin p 17
###xml 113 134 113 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Rombouts et al., 2004</xref>
###xml 136 153 136 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Spoo et al., 2007</xref>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pim1</italic>
###xml 358 375 358 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Spoo et al., 2007</xref>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pim1</italic>
###xml 490 498 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cxcr4</italic>
###xml 605 613 605 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1045 1053 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1379 1399 1379 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pogacic et al., 2007</xref>
###xml 1414 1422 1414 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 765 773 <span type="species:ncbi:9606">patients</span>
###xml 1158 1163 <span type="species:ncbi:9606">human</span>
###xml 1239 1244 <span type="species:ncbi:9606">human</span>
###xml 1342 1347 <span type="species:ncbi:9606">human</span>
Elevated surface CXCR4 expression has been demonstrated to be an adverse prognostic marker in patients with AML (Rombouts et al., 2004; Spoo et al., 2007). Because our results suggest that PIM1 is a regulator of surface CXCR4 expression, we compared pim1 expression levels in leukemic samples that have been previously analyzed for surface CXCR4 expression (Spoo et al., 2007). A tendency for higher pim1 expression in AML samples with high CXCR4 surface expression was observed (P < 0.05; Fig. 5 A, left). In contrast, we found no correlation between surface CXCR4 and cxcr4 messenger RNA (mRNA) levels (Fig. 5 A, right). These results suggest that PIM1 signaling is necessary for increased CXCR4 surface expression. When freshly isolated leukemic blasts from six patients with newly diagnosed AML expressing high surface CXCR4 levels received short-term treatment with the PIM inhibitor (K00486), a significant decrease in steady-state surface CXCR4 expression was observed in four out of six samples without significantly impaired viability (Fig. 5 B). These observations suggest that PIM1 is an important regulator of surface CXCR4 expression in primary human cancer cells. To determine if elevated PIM1 levels that are often found in human cancers might affect CXCR4 function, we evaluated migration of Ba/F3 cells stably overexpressing human PIM1 toward a CXCL12 gradient (Pogacic et al., 2007). As shown in Fig. 5 C, transmigration toward a gradient of 10 nM CXCL12 was significantly enhanced for PIM1-overexpressing cells and was significantly impaired in the presence of the PIM inhibitor.
###end p 17
###begin p 18
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression and regulation of PIM1 and CXCR4 in primary AML blasts.</bold>
###xml 204 222 204 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Spoo et al. [2007]</xref>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 329 336 <span type="species:ncbi:9606">patient</span>
###xml 545 553 <span type="species:ncbi:9606">patients</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
Expression and regulation of PIM1 and CXCR4 in primary AML blasts. (A) Expression of PIM1 and CXCR4 mRNA in leukemic cells from AML patients with high versus low surface CXCR4 expression (as described in Spoo et al. [2007]) by quantitative real-time PCR analysis. The values are normalized to GAPDH levels and represent each AML patient (diamond) and median values (bars) of two independent experiments performed in triplicate (one-way ANOVA: *, P </= 0.05). (B) Regulation of surface CXCR4 expression in primary blasts from four out of six AML patients upon treatment with the K00486 PIM inhibitor. Data represents one of two independent experiments. (C) BaF/3 cells stably overexpressing human PIM1, as well as WT BaF/3 cells, were allowed to migrate toward a 10-nM CXCL12 gradient in the presence or absence of 10 microM of the K00486 PIM inhibitor for 2 h. The migration index was calculated as a percentage of input cells. Data represent the mean +/- SD of three experiments (one-way ANOVA: **, P </= 0.01).
###end p 18
###begin p 19
###xml 116 141 116 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Busillo and Benovic, 2007</xref>
###xml 325 333 325 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 475 492 475 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Ding et al., 2003</xref>
###xml 1054 1062 1038 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
CXCR4 expression is regulated by ligand-induced internalization and surface reexpression of a significant fraction (Busillo and Benovic, 2007). To address a functional connection of CXCR4 and PIM1, we followed CXCR4 surface expression in JURKAT cells upon stimulation with CXCL12 in presence or absence of the PIM inhibitor (Fig. 6 A). In analogy to previous studies, 1.5 h after exposure of JURKAT cells to 10 nM CXCL12, the majority of surface CXCR4 has been internalized (Ding et al., 2003). Washing out of the CXCL12 after 30 min resulted in rapid reexposure of surface CXCR4 to approximately80% of the starting level. Pretreatment of the cells with 10 microM of the PIM inhibitor for 1 h before CXCL12 addition increased the fraction of internalized CXCR4 to >90% after 1.5 h. Interestingly, surface CXCR4 reappearance after washing out was significantly impaired, reading only 40% of the starting level. To visualize the observed effects, we analyzed CXCR4 expression by immunofluorescent staining at the end of the experiment (3.5 h). As shown in Fig. 6 B, CXCL12 treatment resulted in internalization of a significant fraction of CXCR4 and washing out almost completely restored surface CXCR4. In presence of the PIM inhibitor, CXCL12 treatment also led to CXCR4 internalization; however, after washing out, an important fraction of the receptor remained internalized.
###end p 19
###begin p 20
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Functional inhibition of PIM1 impairs surface expression or reexpression of CXCR4.</bold>
Functional inhibition of PIM1 impairs surface expression or reexpression of CXCR4. (A) Delayed ligand-induced surface expression or reexpression of CXCR4 in the presence of PIM1 inhibitor shown by flow cytometric evaluation in JURKAT cells. 0.5-h treatment with 10 nM CXCL12 before wash allows induction of recycling of CXCR4 on the cell surface evaluated 1, 2, and 3 h after wash compared with nonwashed cells. Recycling is delayed when cells are pretreated for 1 h with 10 microM of the PIM inhibitor (K00486). Data represent the mean of three independent experiments. (B) Confocal immunofluorescence analysis of distribution of CXCR4 in JURKAT cells after 3.5 h of treatment as mentioned in A. The left column shows CXCR4 distribution without PIM inhibitor, the right column shows CXCR4 distribution with treatment of 10 microM of the PIM inhibitor (K00486). The figure illustrates one out of three independent experiments. Bar, 10 microm. (C) JURKAT E cells were transduced with pLMP hPIM1-siRNA or control vector. After 1 h of treatment with CXCL12, the cells were washed. Surface expression of CXCR4 was analyzed before and after CXCL12 stimulation and 1, 2, and 3 h after wash. Data represent the mean +/- SD of two independent experiments performed in duplicates.
###end p 20
###begin p 21
###xml 517 525 505 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 113 118 <span type="species:ncbi:9606">human</span>
We next followed surface CXCR4 expression in JURKAT cells that have been transduced with a retrovirus expressing human PIM1-specific siRNA, leading to significant down-regulation of PIM1 protein expression (). The cells were stimulated with 10 nM CXCL12 for 30 min before washing out the ligand. Similar to treatment with PIM inhibitor, siRNA-mediated PIM1 knockdown in JURKAT cells significantly impaired CXCR4 surface reexpression (measured 1, 2, and 3 h after washout) to approximately50% of the WT control cells (Fig. 6 C). Collectively, these experiments suggest that PIM1 might play an important role for proper surface reexpression of CXCR4.
###end p 21
###begin p 22
###xml 506 531 506 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Busillo and Benovic, 2007</xref>
###xml 713 721 713 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1504 1512 1500 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1680 1688 1676 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 2131 2151 2127 2147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Woerner et al., 2005</xref>
###xml 2411 2419 2407 2415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 2553 2561 2549 2557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 D</xref>
###xml 2685 2693 2681 2689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 D</xref>
###xml 2893 2901 2889 2897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 E</xref>
###xml 3004 3005 3000 3001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
Functional regulation of CXCR4 by PIM1 activity raised the question of whether PIM1 kinase directly modifies the CXCR4 receptor. In support of a direct association, immunolocalization studies in JURKAT cells showed partially overlapping signals for CXCR4 and PIM1 predominantly in the cytoplasm (Fig. S8 B). CXCR4 undergoes ligand-dependent and ligand-independent endocytosis and surface reexpression depending on the integrity of the intracellular C-terminal domain rich in serine and threonine residues (Busillo and Benovic, 2007). We identified three putative PIM1 consensus sites in this region (S325, S330, and S339) containing either the preferred -5 or -3 arginine (position relative to the target serine; Fig. 7 A). To assess their potential as a PIM1 phosphorylation site, the C-terminal 46 residues of CXCR4 were expressed as a GST fusion protein (GST-C46) and treated in vitro with purified PIM1 protein. A single PIM1-dependent phosphorylation was detected by a shift of +80 Da in the intact protein mass as determined by electrospray ionization liquid chromatography/mass spectrometry, whereas no phosphorylation was detected on GST alone. To further define the phosphorylation site, a series of C-terminal deletion constructs were prepared, treated with PIM1, and analyzed by mass spectrometry. Phosphorylation was observed for short deletions, including the construct GST-C46Delta13, but was lost upon further truncation, locating the likely substrate site to the C-terminal residue S339 (Fig. 7 A). To confirm this result, the phosphorylation reaction was repeated with an 11-mer peptide derived from this site and a similar peptide containing the mutation S339A (Fig. 7 B). Importantly, MALDI TOF experiments revealed PIM1-dependent phosphorylation of the WT peptide but not the S339A mutant peptide. This data suggests that PIM1 regulation of CXCR4 results from direct phosphorylation of the C-terminal domain. Generation of a phosphospecific antibody has previously allowed the demonstration that phosphorylation of CXCR4-S339 occurs upon stimulation of brain cancer cells by CXCL12 or by phorbol-ester or EGFR (Woerner et al., 2005). We used this antibody in a series of in vitro kinase assays to show that PIM1-dependent phosphorylation of CXCR4 was lost specifically in the S339A mutant but not in the mutants S325A or S330A, which correspond to the other putative PIM1 recognition sites (Fig. 7 C). Treatment of JURKAT cells with the PIM1 inhibitor K00486 resulted in reduced CXCL12 and PMA-induced phosphorylation of CXCR4-S339 (Fig. 7 D, top). Similarly, reduced CXCL12-induced phosphorylation of CXCR4-S339 was observed upon siRNA-mediated knockdown of PIM1 (Fig. 7 D, bottom). In vitro kinase assays furthermore demonstrated that PIM1, but not PIM2, is able to efficiently phosphorylate CXCR4-S339, whereas BAD is phosphorylated by both kinases to a similar extent (Fig. 7 E). These observations suggest that kinase active PIM1, but not PIM2, can regulate CXCR4 phosphorylation.
###end p 22
###begin p 23
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIM1 phosphorylates the CXCR4 C terminus at serine 339.</bold>
###xml 1611 1627 1607 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pLMP hPIM1-siRNA</italic>
###xml 165 170 <span type="species:ncbi:9606">human</span>
PIM1 phosphorylates the CXCR4 C terminus at serine 339. (A) Deletion series defining the CXCR4 C-terminal region phosphorylated by PIM1. Schematic representation of human CXCR4 showing the C-terminal 46 aa expressed as a GST fusion (CXCR4 region boxed in blue). Three putative PIM1 recognition sites are shown in red. A series of C-terminal truncations map PIM1 phosphorylation to a peptide region including S339 (indicated by shaded area; ESI-LC/MS spectra, not shown). (B) Identification of Ser339 as a PIM1 phosphorylation site. MALDI TOF spectra of an 11-mer CXCR4 peptide (shaded sequence from A) show PIM1 phosphorylation of the WT sequence but not of a mutant S339A peptide. Inset box shows detail of the WT phosphorylation with or without PIM1 treatment. Spectra of the phosphorylated peptide are offset for clarity. The figure represents one out of two independent analyses. (C) In vitro kinase assay performed with different CXCR4 C-terminal mutants confirms that CXCR4 is phosphorylated by PIM1 at serine 339. Protein is detected by anti-PIM1 or anti-phospho-CXCR4 (Ser339) antibody. The blot represents one out of three independent experiments. (D, top) Determination of the CXCR4-Ser339 phosphorylation state in JURKAT cells incubated for 0.5 h with 10 nM CXCL12 or 40 nM PMA with or without a 1-h pretreatment with 10 microM of PIM inhibitor (K00486) before a 2-h wash. CXCR4-Ser339 phosphorylation is inhibited in the presence of PIM inhibitor. Values are the mean of two independent experiments. (D, bottom) Determination of CXCR4-Ser339 phosphorylation state in JURKAT E cells, transduced with pLMP hPIM1-siRNA or control vector and incubated for 0.5 h with 10 nM CXCL12, followed by a 2-h wash. The blot represents one out of two independent experiments. (E) In vitro kinase assay performed with CXCR4 C-terminal mutant C46 shows that CXCR4 is phosphorylated by PIM1 at serine 339 but not by PIM2. BAD phosphorylation was used as positive control to confirm enzyme activity of PIM1 and PIM2. The blot represents one out of two independent experiments.
###end p 23
###begin title 24
DISCUSSION
###end title 24
###begin p 25
###xml 498 517 498 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Mizuki et al., 2003</xref>
###xml 519 535 519 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kim et al., 2005</xref>
###xml 537 554 537 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adam et al., 2006</xref>
###xml 556 576 556 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Agrawal et al., 2008</xref>
###xml 764 770 764 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 1014 1031 1014 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Adam et al., 2006</xref>
###xml 1033 1053 1033 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Agrawal et al., 2008</xref>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 1198 1203 <span type="species:ncbi:10090">mouse</span>
Several lines of evidence suggest that the family of PIM serine/threonine kinases plays an important role in the pathogenesis of hematological malignancies. PIM kinases have been reported as being deregulated by oncogenic PTK fusions, such as the FLT3-ITD mutant found in up to a third of human AMLs. These studies have produced partly conflicting results regarding the role of PIM1 or PIM2 (which are both expressed in the hematopoietic system) in the pathogenesis of PTK-mediated leukemogenesis (Mizuki et al., 2003; Kim et al., 2005; Adam et al., 2006; Agrawal et al., 2008). Our study addressed the role of PIM kinases in primary cells, and the results showed that transformation of hematopoietic cells by FLT3-ITD in vitro and in vivo is independent of PIM2 (Fig. 1). This finding is unexpected, as previous work demonstrated that targeting of PIM2 by siRNA or by expressing dominant-negative kinase dead mutants (PIM-KD) significantly impaired growth and survival or FLT3-ITD-expressing hematopoietic cells (Adam et al., 2006; Agrawal et al., 2008). However, the previous experiments were performed in immortalized cell lines that stably express FLT3-ITD, whereas in the present work primary mouse bone marrow cells were used.
###end p 25
###begin p 26
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 238 258 238 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Mikkers et al., 2004</xref>
###xml 563 581 563 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Domen et al., 1993</xref>
###xml 922 925 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MigRI</italic>
###xml 1170 1173 1170 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1465 1471 1465 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1536 1539 1536 1539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1593 1599 1593 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 1738 1741 1738 1741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 638 643 <span type="species:ncbi:10090">mouse</span>
###xml 1540 1544 <span type="species:ncbi:10090">mice</span>
The PIM kinases have been identified through serial retroviral gene tagging in c-myc-induced lymphomas in WT mice, as well as in PIM knockout mice, suggesting that the loss of one PIM can be compensated for by deregulation of the others (Mikkers et al., 2004). However, there are studies suggesting that in some situations, the loss of a particular PIM kinase may not be compensated for by the presence of other PIMs. For example, the growth of bone marrow-derived mast cells from PIM1 knockout animals is significantly reduced despite induction of PIM2 by IL-3 (Domen et al., 1993). Our present work clearly demonstrates that in primary mouse bone marrow cells expressing FLT3-ITD, the lack of PIM1 cannot be compensated for by the presence of PIM2. Using bone marrow reconstitution assays, we show that FLT3-ITD induces a lethal myelo- and lymphoproliferative disorder in vivo in the absence of PIM2. Interestingly, PIM1-/- cells expressing an empty retrovirus (MigRI) or FLT3-ITD transplanted in a sublethally irradiated host were detectable but gradually declined over several weeks after transplant (unpublished data). Transplantation of an identical number of PIM1-/- cells into lethally irradiated hosts resulted in early death (2-4 wk) of all recipients, suggesting that cells lacking PIM1 have an inherent homing defect, which was further confirmed in a series of experiments measuring homing to the bone marrow and the spleen 4 and 20 h after transplant (Fig. 2). However, expression of FLT3-ITD in bone marrow cells from PIM1-/- mice resulted in generally impaired growth in vitro (Fig. 1 and Fig. S1), indicating that these cells do not only display a homing defect but also have a growth disadvantage compared with WT or PIM2-/- bone marrow cells.
###end p 26
###begin p 27
###xml 324 348 324 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Juarez and Bendall, 2004</xref>
###xml 350 370 350 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Lapidot et al., 2005</xref>
###xml 372 394 372 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Burger and Kipps, 2006</xref>
###xml 396 418 396 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ratajczak et al., 2006</xref>
###xml 595 613 595 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Peled et al., 1999</xref>
###xml 615 633 615 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Tavor et al., 2004</xref>
###xml 776 778 776 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 824 830 824 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1085 1092 1085 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figs. 4</xref>
###xml 1097 1098 1097 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">5</xref>
###xml 1284 1290 1284 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 595 600 <span type="species:ncbi:107322">Peled</span>
Homing of HSCs to the bone marrow niche is a complex and still poorly understood process involving several signaling pathways. There is strong evidence that interaction of the chemokine CXCL12, which is expressed on stroma cells, with its receptor CXCR4, which is expressed on HSCs, plays an essential role in this process (Juarez and Bendall, 2004; Lapidot et al., 2005; Burger and Kipps, 2006; Ratajczak et al., 2006). Proper functioning of the CXCL12-CXCR4 axis seems to be crucial for directing homing/engraftment of normal, as well as leukemic, HSCs into bone marrow after transplantation (Peled et al., 1999; Tavor et al., 2004). Our results provide strong evidence that PIM1 can functionally regulate CXCR4. Absence of PIM1 is associated with impaired CXCL12-induced Ca2+ flux and activation of downstream effectors (Fig. 3). In addition, functional down-regulation by siRNAs, expression of a dominant-negative-acting kinase-dead mutant, or treatment with a small molecule PIM kinase inhibitor leads to down-regulation of CXCR4 expression at the surface of hematopoietic cells (Figs. 4 and 5). In addition, colocalization studies, as assessed by immunofluorescence, and in vitro kinase assays suggest that PIM1 may directly modify the intracellular C-terminal domain of CXCR4 (Fig. 7 and Fig. S8 B). However, we cannot rule out that kinase-active PIM1 indirectly regulates the phosphorylation of CXCR4 through another yet unidentified kinase.
###end p 27
###begin p 28
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 166 184 166 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Domen et al., 1993</xref>
###xml 186 192 186 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 382 385 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
Our results show that PIM1 regulates surface expression of CXCR4. PIM1-/- hematopoietic cells have a subtle but measurable defect in cytokine-mediated proliferation (Domen et al., 1993; Fig. 1). Therefore, it is very likely that impaired in vivo homing of PIM1-/- marrow cells might be the result of inappropriate function of several PIM targets including CXCR4. Interestingly, PIM1-/- marrow cells do not completely lack CXCR4. In fact, they express less surface CXCR4, most probably as a consequence of inappropriate reexpression. As PIM1-/- mice are viable and have a normal lifespan, a lower amount of surface CXCR4 seems to be sufficient to regulate steady-state hematopoiesis.
###end p 28
###begin p 29
###xml 107 132 107 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Busillo and Benovic, 2007</xref>
###xml 381 400 381 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Orsini et al., 1999</xref>
###xml 402 431 402 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Pelchen-Matthews et al., 1999</xref>
###xml 648 670 648 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Hernandez et al., 2003</xref>
###xml 811 836 811 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Busillo and Benovic, 2007</xref>
###xml 1017 1023 1017 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 1165 1171 1165 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 1312 1335 1312 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Masztalerz et al., 2007</xref>
###xml 1502 1508 1502 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 1698 1719 1698 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bullock et al., 2005a</xref>
###xml 1850 1870 1850 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Woerner et al., 2005</xref>
###xml 2006 2026 2006 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Soriano et al., 2003</xref>
###xml 2114 2134 2114 2134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Wingett et al., 1996</xref>
###xml 2244 2250 2244 2250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(WAF1)</sup>
###xml 2397 2413 2393 2409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Aho et al., 2004</xref>
###xml 2415 2431 2411 2427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Jin et al., 2005</xref>
###xml 2433 2449 2429 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Kim et al., 2006</xref>
###xml 2451 2466 2447 2462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Oh et al., 2006</xref>
###xml 2468 2486 2464 2482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Zhang et al., 2007</xref>
###xml 3081 3089 3077 3085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
G protein-coupled receptors like CXCR4 are regulated by desensitization, internalization, and degradation (Busillo and Benovic, 2007). CXCR4 seems to undergo ligand-dependent and -independent internalization and surface reexposure in hematopoietic cells. In both internalization and reexposure of CXCR4, the serine/threonine-rich intracellular C terminus seems to play a key role (Orsini et al., 1999; Pelchen-Matthews et al., 1999). Natural mutants in patients with WHIM syndrome, as well as artificial truncation and alanine scanning mutagenesis, have suggested multiple regions in the CXCR4 C-terminal domain as potential phosphoacceptor sites (Hernandez et al., 2003). However, although multiple protein kinases have been proposed (PKC, GRK3, and GRK6), no specific kinase has yet to be clearly implicated (Busillo and Benovic, 2007). In this study, we observed that functional interference of PIM1 leads to a decrease in CXCR4 surface expression, whereas the total amount of the CXCR4 protein remains unchanged (Fig. 3). In addition, our work suggests that PIM1 regulates surface reexpression, whereas internalization of the receptor seems to be not affected (Fig. 6). A similar phenotype has been observed in T cells deficient in SYT3 (synaptotagmin 3), although the underlying mechanism remained unclear (Masztalerz et al., 2007). Our experiments using mass spectrometry and in vitro kinase assays show that PIM1 is able to directly phosphorylate Ser339 in the CXCR4 C-terminal domain in vitro (Fig. 7). It is worth noting that this site is in a motif that closely resembles the consensus PIM recognition motif with -5 arginine and -2 histidine although the preferred -3 arginine is absent (Bullock et al., 2005a). The CXCR4 Ser339 is known being phosphorylated in brain cancer cells upon stimulation with CXCL12, phorbol-ester (PMA), or EGF (Woerner et al., 2005). Interestingly, both CXCL12-CXCR4 and EGF-EGFR lead to activation of the JAK-STAT signaling pathway, which regulates PIM1 expression (Soriano et al., 2003), whereas PMA treatment is also known to produce a rapid induction of PIM1 expression (Wingett et al., 1996). As some of the PIM1 target sites, like the apoptosis regulator BAD (Ser112) or the cell cycle regulator p21(WAF1) (Thr145/Ser146), are also phosphorylated by other protein kinases, such as RAF1, PAK5, RSK2/5 for the former and PKC-delta or AKT for the latter (Aho et al., 2004; Jin et al., 2005; Kim et al., 2006, Oh et al., 2006; Zhang et al., 2007), it is unlikely that PIM1 is the only kinase that phosphorylates CXCR4-Ser339. Although the exact mechanisms remain to be elucidated, based on our results, PIM1-regulated phosphorylation of CXCR4-S339 could provide an interaction platform for proteins that regulate receptor surface reexpression. Elevated PIM1 levels frequently observed in leukemia and solid tumors would facilitate CXCL12-mediated signaling by increasing surface reexpression of the receptor. This hypothesis is supported by our observation of significantly increased migration toward CXCL12 in cells that overexpress PIM1 (Fig. 5 C).
###end p 29
###begin p 30
###xml 169 192 169 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Lataillade et al., 2002</xref>
###xml 406 430 406 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Juarez and Bendall, 2004</xref>
###xml 432 452 432 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Sipkins et al., 2005</xref>
###xml 454 476 454 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Burger and Kipps, 2006</xref>
###xml 596 617 596 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Rombouts et al., 2004</xref>
###xml 619 636 619 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Spoo et al., 2007</xref>
###xml 809 826 809 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Zeng et al., 2006</xref>
###xml 828 847 828 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Juarez et al., 2007</xref>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
Interaction of CXCL12 with CXCR4 does not only provide signals for efficient migration and homing, but seems also to support survival of hematopoietic progenitor cells (Lataillade et al., 2002). There is increasing evidence that CXCR4 is a key regulator of homing and retention of leukemic stem cells within the marrow niche, allowing these cells to escape spontaneous and chemotherapy-induced cell death (Juarez and Bendall, 2004; Sipkins et al., 2005; Burger and Kipps, 2006). These findings are supported by the negative prognostic impact of high CXCR4 expression levels in patients with AML (Rombouts et al., 2004; Spoo et al., 2007). Consequently, targeting leukemic stem cells within the bone marrow by disruption of the CXCL12-CXCR4 interaction by small molecule inhibitors has been recently proposed (Zeng et al., 2006; Juarez et al., 2007).
###end p 30
###begin p 31
###xml 130 138 130 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 496 516 496 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pogacic et al., 2007</xref>
###xml 712 720 712 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 578 586 <span type="species:ncbi:9606">patients</span>
The association of elevated PIM1 expression with expression of high levels of surface CXCR4 in leukemic blasts from AML patients (Fig. 5 A) suggests that targeting aberrant PIM activity by small molecules would be rather promising by its effects on interfering not only with self-renewal but also with migration and homing of leukemic cells. Indeed, structural analysis of PIM1 has allowed us to identify a group of selective small molecule inhibitors with potent antileukemic activity in vitro (Pogacic et al., 2007). Short-term treatment of fresh leukemic blasts from six AML patients with the PIM inhibitor (K00486) resulted in a significant decrease of steady-state surface CXCR4 expression in four samples (Fig. 5 B). Ongoing experiments aim to understand why some AML blasts are resistant to CXCR4 regulation after treatment with the PIM inhibitors.
###end p 31
###begin p 32
###xml 599 604 <span type="species:ncbi:9606">human</span>
Collectively, we have dissected the role of PIM serine/threonine kinases for FLT3-ITD leukemogenesis in vitro and in vivo. Our work demonstrated that PIM2 is dispensable for transformation by FLT3-ITD and cells lacking PIM1 are impaired for growth and survival that cannot be overridden by FLT3-ITD. Most importantly, our work demonstrates that PIM1 activity directs cellular homing and migration by regulation of surface CXCR4 expression, suggesting that increased PIM1 expression supports CXCL12-CXCR4-mediated homing of leukemic stem cells and could also be implicated in metastasis formation in human cancer.
###end p 32
###begin title 33
MATERIALS AND METHODS
###end title 33
###begin title 34

###end title 34
###begin title 35
DNA constructs and growth factors.
###end title 35
###begin p 36
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MigRI</italic>
###xml 269 290 269 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Grundler et al., 2005</xref>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MigRI</italic>
###xml 344 364 344 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pogacic et al., 2007</xref>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pLMP</italic>
###xml 606 624 606 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA3-hCXCR4fusin</italic>
###xml 778 805 778 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGEX-2T. pcDNA3.1-HA-hCXCR4</italic>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 293 298 <span type="species:ncbi:10090">Mouse</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
The complementary DNA (cDNA) of mouse FLT3-ITD was provided by H. Serve (University of Frankfurt, Frankfurt, Germany). The retroviral vector was constructed by cloning the FLT3-ITD cDNA into the MigRI retroviral vector coexpressing the green fluorescent protein (EGFP; Grundler et al., 2005). Mouse PIM1 in MigRI has been described previously (Pogacic et al., 2007). Retroviral constructs (pLMP) expressing mouse and human PIM-specific siRNAs have been obtained through Open Biosystems (mPIM1, VMM_46214; mPIM2, VMM_194110; hPIM1, V2HS_170016). A cDNA fragment coding for the 46 C-terminal CXCR4 residues (pcDNA3-hCXCR4fusin was provided by V. Piguet, Geneva University Hospital, Geneva, Switzerland) and various deletion and point mutants were generated by PCR and cloned into pGEX-2T. pcDNA3.1-HA-hCXCR4 was provided by M. Biard-Piechaczyk (Institut de Biologie, Montpelier, France). Recombinant IL-3, IL-6, and mouse stem cell factor were purchased from R&D Systems.
###end p 36
###begin title 37
Cell culture, retrovirus preparation, and helper virus assay.
###end title 37
###begin p 38
###xml 259 280 259 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Grundler et al., 2005</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 79 84 <span type="species:ncbi:9606">Human</span>
Mouse Ba/F3 cells were grown in RPMI-1640 containing 1 ng/ml IL-3 and 10% FCS. Human JURKAT T cells were obtained through the DSMZ (Braunschweig, Germany) and kept in RPMI-1640 containing 10% FCS. Retrovirus preparation was performed as described previously (Grundler et al., 2005).
###end p 38
###begin title 39
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Transduction and transplantation of mouse bone marrow.
###end title 39
###begin p 40
###xml 78 99 78 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Grundler et al., 2005</xref>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIM1</italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIM2</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 403 408 <span type="species:ncbi:10090">mouse</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
Syngenic bone marrow transplantations were performed as previously described (Grundler et al., 2005). Bone marrow was harvested from FVB/N (WT), FVB/N PIM1-/-, and FVB/N PIM2-/- donor mice (provided by A. Berns and M. Nawijn, The Netherlands Cancer Institute, Amsterdam, Netherlands) and incubated overnight in IMDM/20% FCS supplemented with growth factors (10 ng/ml mIL-3, 10 ng/ml mIL-6, and 50 ng/ml mouse stem cell factor). Cells were transduced in four rounds of spin infection (1,200 g, 32degreesC, 90 min) with 4 microg/ml polybrene (Sigma-Aldrich). Subsequently, cells were resuspended in HBSS (Sigma-Aldrich) and injected into the tail vein of sublethally (750 rad) or lethally (900 rad) irradiated FVB/N recipient mice. All procedures were performed in compliance with the German animal welfare law, reviewed by the supervisory animal care committee of the Technical University Munich, and approved by the government of Upper Bavaria.
###end p 40
###begin title 41
Flow cytometric immunophenotyping (FACS analysis).
###end title 41
###begin p 42
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
###xml 632 637 <span type="species:ncbi:9606">human</span>
###xml 727 730 <span type="species:ncbi:10116">rat</span>
Single-cell suspensions of indicated tissue samples were prepared by passing tissue through 100-microm nylon mesh strainers (Falcon; BD). Red blood cells of peripheral blood were lysed before analysis. Cells were preincubated with Fc block and CD45-PECy5 and subsequently stained with PE-conjugated anti-CD11b (Mac-1), CD45R/B220, CD90.1 (Thy1.1), CD4, or CD8-alpha antibodies as indicated. Dead cells were excluded by propidium iodide (PI) or 7-amino-actinomycin D (7-AAD) staining as mentioned in the text. Cell surface expression of CXCR4 was analyzed by staining with PE-conjugated anti-mouse CD184 (2B1) or APC-conjugated anti-human CD184 (12G5) antibodies (BD). Unspecific binding was assessed by a PE- or APC-conjugated rat IgG2b as an isotype control. Fc block and all antibodies were purchased from BD.
###end p 42
###begin title 43
Bone marrow cell homing.
###end title 43
###begin p 44
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 406 407 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">Mice</span>
Female recipient FVB/N mice were lethally irradiated (900 rad) 24 h before transplantation. Donor cells of PIM1-/- or WT FVB/N mice were stained with 1 microM CFSE (Invitrogen) according to the manufacturer's instructions. Comparable staining and viability of labeled cells was determined by flow cytometry (FACS). Subsequently, cells were resuspended in HBSS and irradiated mice received transplants of 106 CFSE-stained and viable bone marrow cells via tail vein injection. Mice were killed 4 or 20 h after transplantation as indicated. Single cell suspensions were incubated with Fc-blocking reagent and subsequently stained with PE-CY5-conjugated anti-CD45 antibody. Dead cells were excluded by PI staining. Donor cells in bone marrow and spleen were detected by flow cytometry. The CFSE-stained cells were concurrently cultured in IMDM/20% FCS supplemented with growth factors, and viability was determined by PI staining after 4 and 20 h to exclude differences in viability during the homing process.
###end p 44
###begin title 45
Cellular migration analysis.
###end title 45
###begin p 46
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
5 x 105 bone marrow cells from PIM1-/-, PIM2-/-, and WT FVB/N mice were allowed to migrate 4 h toward a 300-ng/ml CXCL12 gradient using 5.0-microm pore size transwell chambers (Costar). The migration index was calculated as a percentage of input cells. For Ba/F3 and JURKAT cells, migration toward a 10-nM CXCL12 gradient was allowed for 4 h using transwell chambers, when indicated cells were pretreated for 2 h with 10 microM K00486.
###end p 46
###begin title 47
Phosphorylation of GST-CXCR4.
###end title 47
###begin p 48
###xml 57 78 57 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Bullock et al., 2005b</xref>
###xml 465 466 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 481 482 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PIM1 was expressed and purified as described previously (Bullock et al., 2005b). GST-CXCR4 fusions were expressed in BL21 (DE3) cells with 0.5 mM IPTG induction for 6 h at 18degreesC. Lysates were purified by glutathione sepharose chromatography. Phosphorylation reactions were performed for 90 min at room temperature in 125-microl samples containing 1 microM PIM1 and 10 microM GST-CXCR4 buffered in 50 mM Hepes, pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM ATP, 5 mM MgCl2, and 1 mM MnCl2. Control samples were treated similarly in the absence of PIM1. Reactions were stopped by the addition of 0.1% formic acid and protein masses determined by electrospray ionization liquid chromatography/mass spectrometry.
###end p 48
###begin title 49
In vitro kinase assay.
###end title 49
###begin p 50
###xml 127 128 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 240 260 222 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pogacic et al., 2007</xref>
###xml 626 646 604 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Woerner et al., 2005</xref>
###xml 144 150 <span type="species:ncbi:9913">bovine</span>
5 microg of recombinant PIM1 or PIM2 was incubated at 30degreesC for 5 min in kinase buffer (40 mM Tris-HCl, pH 7.4, 20 mM MgCl2, and 0.1 mg/ml bovine serum albumin) containing 500 microM ATP with or without 2 microM PIM inhibitor (K00486; Pogacic et al., 2007). 8 microg of the mentioned GST-CXCR4 construct or BAD-purified protein (Millipore) were then added for a further 10 min. The reactions were terminated by the addition of Laemmli sample buffer. Phosphorylation of CXCR4 was analyzed by Western blotting with anti-phospho-CXCR4 antibody (provided by J. Rubin, Washington University School of Medicine, St. Louis, MO; Woerner et al., 2005). Phosphorylation of BAD was determined by Western blotting with anti-phospho-BAD (Cell Signaling Technology). Equal loading of substrate was evaluated by using anti-GST (GE Healthcare) and anti-BAD (Cell Signaling Technology).
###end p 50
###begin title 51
###xml 45 52 <span type="species:ncbi:9606">patient</span>
CXCR4 expression after PIM inhibition in AML patient samples.
###end title 51
###begin p 52
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
Mononuclear cells from peripheral blood from AML patients with >90% of leukemic cells were freshly purified using Ficoll gradient. Cells were washed in PBS and seeded in 24-well plates with 106 cells/ml of media containing RPMI and 10% FCS. Cells were treated with DMSO and 5 or 10 microM K00486. After 30 min of treatment, cells were fixed in 3.75% PFA, and CXCR4 surface expression was measured using APC-conjugated anti-human CD184 (12G5) antibody. The work with clinical samples was approved by the ethics board of the Albert-Ludwigs-University Freiburg, Germany (Project 163/03).
###end p 52
###begin title 53
Regulation of CXCR4 surface expression.
###end title 53
###begin p 54
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pLMP</italic>
###xml 44 54 44 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pLMP-hPIM1</italic>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 631 636 <span type="species:ncbi:9606">human</span>
###xml 720 723 <span type="species:ncbi:10116">rat</span>
JURKAT or JURKAT-E (transduced with pLMP of pLMP-hPIM1) cells were plated in RPMI complete at a concentration of 105/ml and pretreated for 1 h with 10 microM K00486 or DMSO at 37degreesC, as indicated. After this treatment, cells were incubated for 30 or 60 min with 10 nM CXCL12 at 37degreesC. Half of the cells were washed three times in PBS to remove CXCL12 and K00486 and resuspended in new medium, and the rest were left in the original medium. Samples were collected right after the CXCL12 treatment and 1, 2, and 3 h after washing. Cells were fixed in 4% PFA. Surface CXCR4 was analyzed by staining with APC-conjugated anti-human CD184 (12G5) antibody. Nonspecific binding was determined using the APC-conjugated rat IgG2b as isotype control (BD).
###end p 54
###begin title 55
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Determination of intracellular Ca2+ flux.
###end title 55
###begin p 56
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 263 264 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 275 276 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 476 477 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 669 671 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 725 726 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 745 748 735 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 816 819 806 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">min</sub>
The increase in the intracellular calcium concentration ([Ca2+]i) induced by CXCL12 was monitored by fluorescence spectrophotometry. Freshly isolated BM cells were loaded with 1 microM Fura-2-AM (Invitrogen) in calcium buffer (137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, and 0.1% BSA buffered with 20 mM Hepes, pH 7.4). After incubation at 37degreesC for 30 min, cells were washed twice and suspended in calcium buffer to a final concentration of 2 x 106 cells/ml. Fura-2 fluorescence was monitored in an LS50B luminescence spectrophotometer (PerkinElmer). The excitation wavelengths used were 340 and 380 nm; emission was measured at 510 nm. [Ca2+]i was calculated from the Grynkiewicz equation. The Kd used was 224 nM. Rmax was obtained after lysis of the cells with 0.1% Triton X-100, and Rmin was determined by addition of 10 mM EGTA.
###end p 56
###begin title 57
Confocal microscopy analysis.
###end title 57
###begin p 58
###xml 1203 1207 <span type="species:ncbi:9925">goat</span>
###xml 1213 1219 <span type="species:ncbi:9986">rabbit</span>
JURKAT cells were flattened on a glass slide, fixed with acetone for 3 s, and dried overnight. Cells were treated briefly with 0.1 M glycin in PBS followed by 0.3% Triton X-100 in phosphate buffer, incubated overnight at 4degreesC with anti-CXCR4 (Abcam) and anti-PIM1 (12H8) antibodies (Santa Cruz Biotechnology, Inc.), and washed and incubated for 1 h at room temperature with appropriate secondary antibodies (Invitrogen). TOTO-3 iodide (642/660) was used for DNA staining. Confocal microscopy was performed on a laser-scanning confocal microscope (Radiance 2100; Bio-Rad Laboratories) equipped with a krypton/argon laser and a red laser diode. To reduce bleed-through, confocal images were acquired sequentially. Noise reduction is achieved by Kalman filtering during acquisition. Cells harvested at the last time point of the recycling assay were cytospinned and immunolocalization was performed. Cells were permeabilized with 0.5% Triton X-100 in PBS, treated with RNase, and blocking was done in 0.1% Tween-20/PBS supplemented with 1% BSA. The CXCR4 primary antibody (Abcam) was added for 1 h at room temperature, and slides were washed and incubated in the dark for 1 h with the Alexa Fluor 488 goat anti-rabbit antibody (Invitrogen). PI was used for nuclei staining. Slides were washed in mounted with FluorSafe reagent (EMD). Confocal microscopy is carried on a laser-scanning microscope (LSM 510; Carl Zeiss, Inc.).
###end p 58
###begin title 59
MALDI TOF analysis of CXCR4 peptides.
###end title 59
###begin p 60
###xml 262 263 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 279 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
CXCR4 11-mer peptides (WT, KRGGHSSVSTE; and S339A, KRGGHSAVSTE) were phosphorylated for 2 h at room temperature in 300-microl samples containing 3 microM PIM1 and 30 microM CXCR4 peptide buffered in 25 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM DTT, 1 mM ATP, 5 mM MgCl2, and 1 mM MnCl2. Control samples were treated similarly in the absence of PIM1. Samples were desalted using a ZipTipC18 (Millipore) equilibrated with 2% acetonitrile and 0.5% TFA, and bound peptide was washed repeatedly with the same buffer. Peptides were eluted with 2-5 microl of a saturated solution of alpha-cyano-4-hydroxycinnamic acid in 40% ACN and 0.1% TFA and then deposited directly onto a stainless steel target plate and allowed to air dry. The spots were subsequently analyzed using an ultraflex LIFT II mass spectrometer equipped with a 337-nm N2 laser (Bruker Daltonics) and the peak lists were extracted using Flex Analysis software (Bruker Daltonics).
###end p 60
###begin title 61
Immunoblotting.
###end title 61
###begin p 62
Cellular expression of PIM1, PIM2, and CXCR4 was analyzed by Western blot analysis using standardized protocols with the following antibodies: alpha-PIM1 (clone 12H8, 1:1,000), alpha-PIM2 (clone 1D12, 1:1,000; Santa Cruz Biotechnology); alpha-CXCR4 (ab1670, 1:1,000; Abcam); and beta-actin (clone 8AC-15, 1:5,000; Sigma-Aldrich).
###end p 62
###begin title 63
Quantitative real-time PCR analysis.
###end title 63
###begin p 64
mRNA expression was determined by quantitative real-time PCR using SYBR Green. 1 microg of total mRNA (isolated with the RNeasy kit; QIAGEN) was used for cDNA synthesis (High Capacity cDNA Reverse Transcription kit; Applied Biosystems), and 50 ng cDNA was applied for real-time PCR using the Power SYBR Green PCR MasterMix (Applied Biosystems) on an ABI Prism 7700 sequence detection system (Applied Biosystems). Expression levels were normalized to GAPDH using the DeltaCt method. The following oligonucleotides were used as PCR primers: hPIM1 forward, 5'-CGAGCATGACGAAGAGATCAT-3', and hPIM1 reverse, 5'-TCGAAGGTTGGCCTATCTGA-3' (119-bp amplicon); hCXCR4 forward, 5'-ATGAAGGAACCCTGTTCCCGT-3', and hCXCR4 reverse, 5'-AGATGATGGAGTAGATGGTGGG-3' (76-bp amplicon); and hGAPDH forward, 5'-GTGGTCTCCCTGACTTTCAACAGC-3', and hGAPDH reverse, 5'-ATGAGGTCCACCACCTGCTTGCTG-3' (149-bp amplicon). Statistical significance was assessed by one-way ANOVA.
###end p 64
###begin title 65
In vitro colony-forming assays.
###end title 65
###begin p 66
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Bone marrow was transduced according to the method described in Transduction and transplantation of mouse bone marrow. 10-20 x 103 EGFP-positive bone marrow cells per well were plated in triplicate in methylcellulose media containing 10 ng/ml of recombinant IL3 or no cytokines (StemCell Technologies, Inc.).
###end p 66
###begin title 67
Online supplemental material.
###end title 67
###begin p 68
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 585 586 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 592 593 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 664 667 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows that the expression of FLT3-ITD induces growth factor-independent growth in primary mouse bone marrow cells independent of PIM2. Fig. S2 shows the induction of a myeloproliferative disease in mice transplanted with FLT3-ITD expressing WT or PIM2-/- but not PIM1-/- bone marrow. Fig. S3 shows that the absence of PIM2 does not affect the FLT3-ITD-induced phenotype in vivo and summarizes all transplant experiments. Fig. S4 shows the hematopoietic reconstitution of mice transplanted with WT, PIM1-/-, and PIM2-/-. Fig. S5 shows that PIM1 does not influence integrin-alpha4/alpha5 expression. Fig. S6 shows ERK phosphorylation in lineage-negative PIM1-/- cells. Fig. S7 shows that the expression of a dominant-negative PIM1 mutant decreases surface CXCR4 expression and that the inhibition of PIM affects CXCL12-induced ERK phosphorylation. Fig. S8 shows the knockdown efficacy of PIM1 and the immunolocalization of PIM1 and CXCR4 in JURKAT cells. Online supplemental material is available at .
###end p 68
###begin title 69
Supplementary Material
###end title 69
###begin title 70
[Supplemental Material]
###end title 70
###begin p 71
We would like to thank M. Wymann, D. Jankovic, V. Stavropoulou, T. Liu, B. Erne, Pamela della Mina, V. Jaeggin, and U. Schibler for their inputs and help and R. Skoda for critically reading the manuscript.
###end p 71
###begin p 72
This work has been supported by Oncogene networks in AML to R. Grundler and J. Duyster, funded by the Mildred Scheel Stiftung, and by a grant from the Jose Carreras Stiftung to J. Duyster. This work has also been supported by grants from the Swiss National Science Foundation (SNF-3100AO-116587/1), ONOCOSUISSE (OCS-01830-02-2006), the Susy-Rueckert Foundation and the Krebsliga beider Basel (Basel, Switzerland), and the Wilhelm Sander Foundation (2008.048.1, Munich, Germany) to J. Schwaller. J. Schwaller is a research professor supported by the Gertrude von Meissner Foundation. The Structural Genomics Consortium is a registered charity organization (number 1097737).
###end p 72
###begin p 73
The authors have no conflicting financial interests.
###end p 73
###begin article-title 74
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
###end article-title 74
###begin article-title 75
Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation.
###end article-title 75
###begin article-title 76
###xml 104 114 <span type="species:ncbi:111938">gatekeeper</span>
Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
###end article-title 76
###begin article-title 77
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.
###end article-title 77
###begin article-title 78
Structure and substrate specificity of the Pim-1 kinase.
###end article-title 78
###begin article-title 79
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 96 125 <span type="species:ncbi:11801">moloney murine leukemia virus</span>
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
###end article-title 79
###begin article-title 80
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
###end article-title 80
###begin article-title 81
Regulation of CXCR4 signaling.
###end article-title 81
###begin article-title 82
Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies.
###end article-title 82
###begin article-title 83
Cancer stem cells: implications for the progression and treatment of metastatic disease.
###end article-title 83
###begin article-title 84
L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration.
###end article-title 84
###begin article-title 85
Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells.
###end article-title 85
###begin article-title 86
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Targeting the kinase activity of the BCR-ABL fusion protein in patients with chronic myeloid leukemia.
###end article-title 86
###begin article-title 87
###xml 78 84 <span type="species:ncbi:10090">murine</span>
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
###end article-title 87
###begin article-title 88
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.
###end article-title 88
###begin article-title 89
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
###end article-title 89
###begin article-title 90
p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association.
###end article-title 90
###begin article-title 91
SDF-1 and CXCR4 in normal and malignant hematopoiesis.
###end article-title 91
###begin article-title 92
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
###end article-title 92
###begin article-title 93
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival.
###end article-title 93
###begin article-title 94
Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
###end article-title 94
###begin article-title 95
How do stem cells find their way home?
###end article-title 95
###begin article-title 96
Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism.
###end article-title 96
###begin article-title 97
Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration.
###end article-title 97
###begin article-title 98
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.
###end article-title 98
###begin article-title 99
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
###end article-title 99
###begin article-title 100
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
###end article-title 100
###begin article-title 101
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.
###end article-title 101
###begin article-title 102
PKCdelta modulates p21WAF1/CIP1 ability to bind to Cdk2 during TNFalpha-induced apoptosis.
###end article-title 102
###begin article-title 103
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization.
###end article-title 103
###begin article-title 104
Chemokine receptor trafficking and viral replication.
###end article-title 104
###begin article-title 105
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
###end article-title 105
###begin article-title 106
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
###end article-title 106
###begin article-title 107
The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.
###end article-title 107
###begin article-title 108
Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.
###end article-title 108
###begin article-title 109
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2.
###end article-title 109
###begin article-title 110
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.
###end article-title 110
###begin article-title 111
Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses.
###end article-title 111
###begin article-title 112
CXCR4 is a prognostic marker in acute myelogenous leukemia.
###end article-title 112
###begin article-title 113
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
###end article-title 113
###begin article-title 114
Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back.
###end article-title 114
###begin article-title 115
pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
###end article-title 115
###begin article-title 116
Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies.
###end article-title 116
###begin article-title 117
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.
###end article-title 117
###begin article-title 118
Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells.
###end article-title 118
###begin p 119
Abbreviations used: AML, acute myeloid leukemia; HSC, hematopoietic stem cell; mRNA, messenger RNA; PTK, protein tyrosine kinase; siRNA, small interfering RNA.
###end p 119

